INTRODUCTION AND OBJECTIVES: Squamous cell carcinoma of the bladder (SCC) is the second most common histological subtype of bladder cancer after urothelial carcinoma (UC). We sought to compare clinical outcome and differences in staging between both subtypes.
METHODS: In our institution, follow-up data of 714 patients with pure UC and 39 patients with pure SCC undergoing radical cystectomy (RC) between 2004 and 2015 is available. First, cancer-specific survival (CSS) was analyzed among both subtypes. As a second step, staging, grading and histological subtypes were compared in a multivariate Coxregression analysis. Lastly, distribution of advanced disease (pT3-4, pN+, M1, G3) between UC and SCC was assessed.
RESULTS: CSS of patients with SCC is significant worse compared to UC in a univariate analysis (p¼0.032). In a multivariate analysis only T score pT<3 vs. pT3-4 (hazard ratio [HR] ¼ 3.2; 95% CI: 2.3-4.5, p<0.001), N score pN0 vs. pN+ (HR ¼ 2.0; 95% CI: 1.5-2.6, p<0.001) and M score M0 vs. M1 (HR ¼ 2.8; 95% CI: 2.0-4.0 p<0.001) were significantly associated with CSS. There was no significant impact of grading G1-2 vs. G3 (HR ¼ 1.2; 95% CI: 0.7-1.9 p<0.517) and histological subtype UC vs. SCC (HR ¼ 1.4; 95% CI: 0.8-2.5 p<0.176) on CSS. Compared to UC, SCC presents with pT3-4 nearly twice as often (44% vs. 85%, p<0.001). High grade (G3) is more common in UC compared to SCC (89% vs. 64%, p<0.001). There is no significant difference between N score (UC 28% vs. SCC 29%, p¼0.808) and M score (UC 11% vs. SCC 5%, p¼0.262) between both bladder cancer subtypes.
CONCLUSIONS: Compared to UC, patients with SCC have a decreased CSS. The reason for this phenomenon may not lie within the histological subtype itself, but rather in a more progressive disease at the point of RC. This is reflected by the prevalence of pT3-4 stage, which is nearly twice as often in SCC compared to UC. Future studies concentrating on early detection of SCC should be encouraged in order to improve CSS of the latter bladder cancer entity.
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MP58-18 UNRELIABILITY OF COMPARING LYMPH NODE YIELDS BETWEEN INSTITUTIONS
Ronney Abaza*, Janice Rosenthal, Jatin Gupta, Dublin, OH INTRODUCTION AND OBJECTIVES: Lymph node yield after cystectomy has been proposed as a quality measure for surgeons, but multiple factors beyond surgeon ability are known to impact node count. We previously demonstrated no difference in nodal yield between open and robotic cystectomy (RC) at a single, high-volume academic institution. We now assessed whether institutional variations in specimen processing can impact nodal yield following RC, as has been shown with open surgery, since this could help explain wide variations in yields between institutions performing RC even with similar templates.
METHODS: Consecutive robotic cystectomy procedures performed by a single surgeon with the same assistant were retrospectively reviewed. All procedures were performed with an identical technique and extended template but at two different hospitals including one highvolume academic center with a standardized protocol for node assessment (site A) and one low-volume community hospital (site B). Nodes were dissected en bloc and submitted as no more than one or two specimens.
RESULTS: A total of 57 procedures were performed at site A and 44 at site B. Neoadjuvant chemotherapy was given in 40% of site A and 27% of site B patients (p¼0.04). Mean body mass index was 29kg/m^2 at site A and 27kg/m^2 at site B (p¼0.09). Despite an identical surgical team, technique, and template, a significant difference in mean node count was identified between the two hospitals with a mean of 34 nodes (range 10-67) at site A and 22 nodes (range 7-40) at site B (p<0.01). There was no difference in the proportion of patients found to have involved lymph nodes on pathologic examination at 32% and 32%, respectively (p¼0.73). There was also no difference in the mean number of involved nodes identified per patient in those with metastasis (4 vs 6, p¼0.47).
CONCLUSIONS: Variations in nodal yield with RC can be related to differences in institutional handling of nodal specimens. The wide differences in node counts between surgeons performing RC with similar templates may depend more on variations in their pathology departments rather than surgeon ability. This has implications for using Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e779
